Lee John Sang 4
4 · PhaseBio Pharmaceuticals Inc · Filed Feb 9, 2021
Insider Transaction Report
Form 4
Lee John Sang
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-02-05+76,500→ 76,500 totalExercise: $4.31Exp: 2031-02-05→ Common Stock (76,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from February 5, 2021, subject to the reporting person's continued service through each such date.